Breast Cancer Clinical Trial
Official title:
Breast Cancer Risk-Tailored Messages for More Women
RATIONALE: Education, based on a patient's risk factors, may help promote breast cancer
screening in healthy women.
PURPOSE: This randomized clinical trial is studying individualized risk-based education to
see how well it promotes breast cancer screening in healthy women compared to standard
education.
OBJECTIVES:
Primary
- Compare the impact of risk-tailored messages vs standard health information on the
outcome of mammography in healthy women.
Secondary
- Compare the effect of these interventions on breast self-examination, clinical breast
exam, risk perceptions, and breast cancer worry.
- Compare the mechanism of action of these interventions on participants by assessing the
impact of covariants (coping mechanisms, expanded Health Belief Model variables, breast
cancer worry, breast cancer risk factors including family history, risk perceptions,
discussion of breast cancer with relatives, previous screening practices, intentions to
screen, and various demographic variables—age, race, and education) on breast cancer
screening.
OUTLINE: This is a randomized study.
Participants are approached to complete a baseline survey while they are waiting for their
clinic visits. Baseline surveys measure breast cancer risk factors, current breast cancer
screening practices, intentions to screen, risk perceptions, breast cancer worry, coping
mechanisms, and discussion of breast cancer with relatives. After completion of the baseline
surveys, participants are then randomized to 1 of 2 education arms.
- Arm I (intervention group): Participants undergo a computerized risk assessment
followed by personalized risk-tailored health messages. Health messages are based on
principles of the expanded Health Belief Model (HBM). These messages include screening
and lifestyle recommendations, information on the seriousness of breast cancer,
instructions on how to arrange a mammography appointment, and contact information for
genetic and psychosocial counseling.
- Arm II (control group): Participants receive generalized breast health information
sheets that contain appropriate screening and lifestyle recommendations for the general
public and contact information for genetic and psychosocial counseling.
All participants undergo follow-up assessment by telephone (or by mail if unreachable by
phone) at 1, 6, and 18 months after the initial intervention. Self-reported mammography use,
additional breast health monitoring practices, risk perception, breast cancer worry, coping
mechanisms, HBM-related beliefs, and family communication are measured.
PROJECTED ACCRUAL: A total of 900 participants will be accrued for this study.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |